Edan Instruments, Inc.

Equities

300206

CNE100001252

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
9.7 ^CNY	-3.00%		-4.72%	-5.00%

Mar. 29	Edan Instruments, Inc. Proposes Final Cash Dividend for the Year 2023	CI
Mar. 28	Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022

October 25, 2022 at 05:00 am EDT

Edan Instruments, Inc. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,241.68 million compared to CNY 1,264.05 million a year ago. Revenue was CNY 1,241.68 million compared to CNY 1,264.05 million a year ago.

Net income was CNY 189.74 million compared to CNY 250.81 million a year ago. Basic earnings per share from continuing operations was CNY 0.3264 compared to CNY 0.4326 a year ago. Diluted earnings per share from continuing operations was CNY 0.3264 compared to CNY 0.4326 a year ago.

Latest news about Edan Instruments, Inc.

Edan Instruments, Inc. Proposes Final Cash Dividend for the Year 2023	Mar. 28	CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023	Nov. 14	CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Edan Instruments, Inc. Strengthens its APAC Business Landscape with Thailand Office Launch	23-08-31	CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Edan Instruments, Inc. Announces Final Cash Dividend for the Year 2022, Payable on 28 April 2023	23-04-21	CI
Edan Instruments, Inc. Approves Cash Dividend for the Year 2022	23-04-20	CI
Edan Instruments, Inc. Proposes Final Cash Dividend for the Year 2022	23-03-28	CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Edan Instruments, Inc. Establishes Peru Office, Edan Diagnostics Peru S.A.C. in Lima	23-03-13	CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022	22-10-19	CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
Edan Instruments, Inc. Launches i20	22-07-26	CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022	22-04-22	CI
Edan Instruments, Inc. Approves Distribution for 2021	22-04-21	CI
Edan Instruments, Inc. Announces Appointment of Zheng Quanlu as Independent Director and Zhou Yirong as Non-Employee Supervisors	22-04-21	CI
Edan Instruments Slashes Final Dividend on Lackluster 2021 Earnings	22-03-25	MT
Edan Instruments, Inc. Announces Profit Distribution Proposal for the Year 2021	22-03-24	CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23	CI
Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.	22-02-08	CI
Edan Instruments, Inc.'s Equity Buyback announced on February 9, 2021, has expired with 2,555,300 shares, representing 0.44% for CNY 35.01 million.	22-02-06	CI

Chart Edan Instruments, Inc.

Duration

Period

More charts

Company Profile

Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EDAN INSTRUMENTS, INC.	-5.00%	777M
THERMO FISHER SCIENTIFIC	+4.48%	213B
DANAHER CORPORATION	+3.89%	177B
INTUITIVE SURGICAL, INC.	+12.21%	134B
BOSTON SCIENTIFIC CORPORATION	+17.83%	99.13B
SIEMENS HEALTHINEERS AG	+0.11%	63.47B
EDWARDS LIFESCIENCES CORPORATION	+18.10%	53.69B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	46.36B
AGILENT TECHNOLOGIES, INC.	-1.60%	41.09B
GE HEALTHCARE TECHNOLOGIES INC.	+11.07%	39.3B

Other Advanced Medical Equipment & Technology